New “Cicada” COVID Variant Spreads to 23 Countries: What It Means for Vietnam

A newly resurfaced COVID-19 variant, known as BA.3.2 or the “cicada” variant, is drawing attention from global health experts as it spreads across at least 23 countries, including Vietnam.

While early data suggests the public health risk remains relatively low, the variant’s high number of mutations and its ability to partially evade immunity are raising concerns about future infection waves and vaccine effectiveness.

For international readers, the key takeaway is not alarm, but awareness: this is another reminder that COVID-19 continues to evolve, with implications for travel, public health planning, and regional stability.

Why the “Cicada” Variant Is Getting Attention

BA.3.2 belongs to the Omicron family but stands out due to its unusually high mutation count, estimated at 70 to 75 genetic changes compared to currently dominant strains.

The nickname “cicada” reflects its pattern: first detected in 2024, it appeared to fade before re-emerging unexpectedly in late 2025 and early 2026.

Laboratory data suggests the variant may partially evade immunity built from vaccines or prior infections. However, current vaccines are still expected to provide meaningful protection, particularly against severe illness, hospitalization, and death.

Global Spread: From Europe to the United States and Asia

The variant was first identified in South Africa in late 2024 before gradually appearing in other regions.

• Detected across 23 countries worldwide
• Identified in 25 U.S. states through surveillance systems
• Rapid growth observed in Northern Europe, reaching around 30 percent of cases in countries such as Germany, Denmark, and the Netherlands

Despite this spread, BA.3.2 still represents a relatively small share of total infections globally, and its transmission advantage remains unclear.

Situation in Vietnam: Low Risk but Rising Cases

Vietnam has reported a modest increase in COVID-19 cases, with no fatalities recorded so far in 2026.

Health authorities emphasize that the public should remain cautious but not alarmed. The variant is currently classified as “under monitoring” by global health agencies, with a low public health risk level compared to other circulating Omicron strains.

Does It Cause More Severe Illness?

So far, there is no evidence that BA.3.2 causes more severe disease than previous variants. Symptoms appear consistent with recent COVID-19 trends.

However, experts caution that most findings are still based on laboratory data, with limited real world clinical evidence available.

Uncertainty remains around whether the variant spreads faster or behaves differently in different populations.

Vaccines, Testing, and What Still Works

Current COVID-19 vaccines continue to play a central role in protection, particularly for high risk groups such as older adults and those with underlying conditions.

• Annual booster strategies are increasingly recommended, similar to flu vaccination
• Additional booster doses may be considered for vulnerable populations
• Existing rapid test kits remain effective in detecting the variant

New vaccine formulations are also under development and may include protection against BA.3.2 in upcoming rollout cycles.

Practical Guidance: Stay Prepared, Not Panicked

Health authorities in Vietnam and globally are emphasizing a balanced approach: vigilance without overreaction.

Recommended measures remain familiar:

• Wear masks in crowded or high risk settings
• Maintain hand hygiene
• Ensure good ventilation indoors
• Monitor symptoms and seek medical care when necessary

For international travelers, expatriates, and businesses, the emergence of BA.3.2 is unlikely to trigger immediate restrictions, but it reinforces the importance of contingency planning and health risk awareness.

The Bigger Picture

The “cicada” variant underscores a broader reality: COVID-19 is no longer an acute crisis but an evolving endemic risk.

For Vietnam, the current situation remains stable. For global stakeholders, it is another signal that pandemic era resilience, from healthcare systems to travel protocols, remains a critical part of operating in Asia and beyond.